Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Completed 3Terminated 1

Sponsor Class

NETWORK 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 47Neutropenia 26Lymphoma 25Lymphoma, Non-Hodgkin 12Lymphoma, Large B-Cell, Diffuse 12Neoplasms 11Sarcoma 9Lymphoma, Follicular 9Ovarian Neoplasms 8Lymphoma, Mantle-Cell 8Leukemia 8Hodgkin Disease 8Carcinoma, Non-Small-Cell Lung 8Lung Neoplasms 7Leukemia, Lymphocytic, Chronic, B-Cell 7Triple Negative Breast Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Multiple Myeloma 5Lymphoma, B-Cell, Marginal Zone 5Chemotherapy-induced Neutropenia 5Rhabdomyosarcoma 4Neoplasm Metastasis 4Lymphoma, Large-Cell, Immunoblastic 4Burkitt Lymphoma 4Waldenstrom Macroglobulinemia 3Urinary Bladder Neoplasms 3Testicular Neoplasms 3Sarcoma, Synovial 3Prostatic Neoplasms 3Neurofibrosarcoma 3

Interventions

Cyclophosphamide 20Trastuzumab 12Epirubicin 12Doxorubicin 12Docetaxel 11Paclitaxel 10Filgrastim 8Carboplatin 7Radiotherapy 6Bevacizumab 5Neoadjuvant Therapy 4Lapatinib 4Granulocyte Colony-Stimulating Factor 4Albumin-Bound Paclitaxel 4tipifarnib 3pertuzumab 3pegfilgrastim 3Thiotepa 3Taxes 3Tamoxifen 3Surgical Procedures, Operative 3Melphalan 3Fluorouracil 3Chemotherapy, Adjuvant 3Capecitabine 3130-nm albumin-bound paclitaxel 3Peripheral Blood Stem Cell Transplantation 2Magnetic Resonance Spectroscopy 2Immunohistochemistry 2Flow Cytometry 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Inflammatory Breast Neoplasms × pegfilgrastim × Clear all
NCT00066443 2026-03-27

Epirubicin, Docetaxel, and Pegfilgrastim in Treating Women With Locally Advanced or Inflammatory Breast Cancer

Canadian Cancer Trials Group

Phase 1/2 Completed
93 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00856492 2017-06-27

S0800, Nab-Paclitaxel, Doxorubicin, Cyclophosphamide, and Pegfilgrastim With or Without Bevacizumab in Treating Women With Inflammatory or Locally Advanced Breast Cancer

SWOG Cancer Research Network

Phase 2 Completed
215 enrolled 13 charts
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00310089 2013-06-20

AZD2171 and Combination Chemotherapy in Treating Women With Locally Advanced Breast Cancer

National Cancer Institute (NCI)

Phase NA Completed
33 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡